Akorn closing may prolong asthma med shortages, but treatment options still available

United States News News

Akorn closing may prolong asthma med shortages, but treatment options still available
United States Latest News,United States Headlines
  • 📰 dailyherald
  • ⏱ Reading Time:
  • 56 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 59%

Shortages of albuterol, to treat respiratory conditions persist, but other treatment options are still available

The sudden closure last week of a Gurnee-based pharmaceutical company may prolong shortages of treatments for RSV and asthma.

"However, inhalers and nebulizer treatments should continue to be available," said Gurz."Akorn's presentation was the larger 20 mL inhalation solution, used specifically in hospitals for continuous drug delivery to manage exacerbations of asthma." "It is an absolute requirement," said Song."Every asthmatic should know where they stand with their numbers.""We have been hearing about albuterol shortages for several months as the market has been strained due to the tripledemic ," said Gurz.

"The FDA is reviewing all drugs affected by this closure and is working with the other manufacturers to understand the supply nationwide. If the approved manufacturers cannot meet market demand, the FDA will add those affected medicines to our Drug Shortage webpage and continue working to resolve or lessen the impact of those shortages using all the tools we have available," the agency said.

The shortage has not affected the practice of Dr. Zachary Rubin, a pediatric allergist and immunologist with Oak Brook Allergists.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

dailyherald /  🏆 317. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Albuterol shortage could worsen after asthma drugmaker's closureAlbuterol shortage could worsen after asthma drugmaker's closureA shortage of albuterol, a widely used drug for the treatment of asthma and respiratory syncytial virus, could worsen after a major manufacturer, Akorn, shuttered three of its facilities last month.
Read more »

Gurnee man intentionally crashed into tree in Beach Park, sheriff's office saysGurnee man intentionally crashed into tree in Beach Park, sheriff's office saysThe Lake County sheriff's office says a Gurnee man who struck a tree Wednesday morning in Beach Park crashed intentionally during an argument with his passenger.
Read more »

Gurnee man intentionally drives into tree during argument, seriously injuring himself and passenger, authorities sayGurnee man intentionally drives into tree during argument, seriously injuring himself and passenger, authorities sayA Gurnee man intentionally drove his car into a tree Wednesday during a roadway argument, seriously injuring himself and the Zion woman who was his passenger, authorities said.
Read more »

RSV vaccine: FDA advisers vote in favor of approval for vaccines for older adultsRSV vaccine: FDA advisers vote in favor of approval for vaccines for older adultsThe FDA, which typically follows the committee's recommendations, is expected to decide on approval of the vaccines in May, ahead of RSV's typical winter surge.
Read more »

RSV vaccine: FDA advisers vote in favor of approval for vaccines for older adultsRSV vaccine: FDA advisers vote in favor of approval for vaccines for older adultsThe FDA, which typically follows the committee's recommendations, is expected to decide on approval of the vaccines in May, ahead of RSV's typical winter surge.
Read more »

FDA panel narrowly backs Pfizer RSV vaccine for older adultsFDA panel narrowly backs Pfizer RSV vaccine for older adultsFederal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV. rsv pfizer kprc2 click2houston
Read more »



Render Time: 2025-02-14 16:42:08